Equities

NeuroOne Medical Technologies Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NMTC:NAQ

NeuroOne Medical Technologies Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.8132
  • Today's Change0.059 / 7.84%
  • Shares traded128.66k
  • 1 Year change-28.67%
  • Beta0.6358
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

  • Revenue in USD (TTM)12.10m
  • Net income in USD-3.61m
  • Incorporated2017
  • Employees18.00
  • Location
    NeuroOne Medical Technologies Corp7599 Anagram DrEDEN PRAIRIE 55344-7399United StatesUSA
  • Phone+1 (952) 426-1383
  • Fax+1 (302) 655-5049
  • Websitehttps://nmtc1.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Baird Medical Investment Holdings Ltd31.86m-3.12m29.38m143.00--0.597--0.9223-0.1128-0.11281.221.340.45523.270.8459222,797.30-4.48---7.64--86.94---9.84--1.67-0.3230.3856--17.74--18.57------
Vaso Corp89.11m2.59m31.06m298.0012.021.109.370.34850.01470.01470.50650.16051.1334.0210.28299,030.203.277.375.3614.5660.9159.172.915.991.61--0.01--7.092.82-80.21--3.81--
Ekso Bionics Holdings Inc14.75m-10.66m31.21m61.00--2.49--2.12-5.70-5.707.253.690.57991.362.27241,786.90-41.02-41.01-60.62-52.9053.4852.89-70.74-97.041.09--0.3055---1.945.1925.45---9.22--
Myomo Inc41.64m-12.02m31.26m184.00--2.14--0.7506-0.2885-0.28851.010.38051.653.969.23226,321.70-47.71-55.96-70.30-77.4066.5669.74-28.86-52.922.10--0.2148--69.1753.3624.10--92.10--
RenovoRx Inc928.00k-11.11m34.09m10.00--4.22--36.74-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
Vivos Inc48.63k-3.01m34.10m10.00--15.64--701.21-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
TELA Bio Inc77.06m-39.00m34.40m209.00--20.36--0.4464-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Modular Medical Inc0.00-24.22m34.69m54.00--3.12-----0.5081-0.50810.000.14340.00----0.00-222.79-171.42-294.38-207.14------------0.00-------7.75--57.07--
Neuroone Medical Technologies Corp12.10m-3.61m38.03m18.00--5.33--3.14-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
Precision Optics Corporation Inc21.58m-6.11m38.99m90.00--3.57--1.81-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
Precipio Inc22.80m-1.25m39.28m54.00--2.85162.311.72-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Icecure Medical Ltd2.98m-15.29m39.52m64.00--4.25--13.28-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Cytosorbents Corp34.35m-10.59m39.88m149.00--4.42--1.16-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Heartbeam Inc0.00-20.62m42.02m16.00--103.19-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
electroCore, Inc.29.84m-14.16m44.70m73.00------1.50-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Spectral AI Inc23.17m-16.37m46.34m78.00------2.00-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Data as of Feb 13 2026. Currency figures normalised to NeuroOne Medical Technologies Corp's reporting currency: US Dollar USD

Institutional shareholders

34.85%Per cent of shares held by top holders
HolderShares% Held
Merchant Adventure Investment Advisors LLCas of 31 Dec 20254.20m8.33%
Bleichroeder LPas of 30 Sep 20254.00m7.93%
Sio Capital Management LLCas of 30 Sep 20252.36m4.68%
Bard Associates, Inc.as of 30 Sep 20251.85m3.67%
Perkins Capital Management, Inc.as of 31 Dec 20251.47m2.92%
The Vanguard Group, Inc.as of 31 Dec 20251.29m2.55%
AWM Investment Co., Inc.as of 30 Sep 2025916.67k1.82%
Renaissance Technologies LLCas of 30 Sep 2025692.60k1.37%
Geode Capital Management LLCas of 30 Sep 2025496.83k0.99%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025292.08k0.58%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.